-
NIA Limited Competition: Renewals of, and Revisions to, Existing Alzheimer's Disease Patient Registry Cooperative Agreement Awards (U01 - Clinical Trial Not Allowed)
(PAR-18-715)
National Institute on Aging
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
International Bioethics Research Training Program (D43 Clinical Trial Optional)
(PAR-18-716)
John E. Fogarty International Center
National Human Genome Research Institute
Application Receipt Date(s): May 17, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional)
(PAR-18-717)
John E. Fogarty International Center
National Institute on Alcohol Abuse and Alcoholism
National Cancer Institute
National Institute on Drug Abuse
National Institute of Mental Health
Application Receipt Date(s): August 23, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Coordinating Center to Support NIDA Rural Opioid HIV and Comorbidity Initiative (U24 - Clinical Trial Not Allowed)
(RFA-DA-19-004)
National Institute on Drug Abuse
Application Receipt Date(s): August 15, 2018, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates.
-
Bioequivalence of Topical Products: Elucidating the Thermodynamic and Functional Characteristics of Compositionally Different Topical Formulations (U01)
(RFA-FD-18-010)
Food and Drug Administration
Application Receipt Date(s): May 21, 2018, by 11:59 PM Eastern Time.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.
Late applications will not be accepted for this FOA.
-
Renewal Applications: Centers of Excellence in Regulatory Science and Innovation
(RFA-FD-18-011)
Food and Drug Administration
Application Receipt Date(s): June 4, 2018, by 11:59 PM Eastern Time.
-
Bioequivalence of Topical Products: Evaluating the Cutaneous Pharmacokinetics of Topical Drug Products Using Non-Invasive Techniques
(RFA-FD-18-012)
Food and Drug Administration
Application Receipt Date(s): June 4, 2018, by 11:59 PM Eastern Time.
-
Computational fluid dynamics (CFD) and discrete element modeling (DEM) approach for predictions of dry powder inhaler (DPI) drug delivery
(RFA-FD-18-014)
Food and Drug Administration
Application Receipt Date(s): May 29, 2018, by 11:59 PM Eastern Time.
-
Characterize skin physiology parameters utilized in dermal physiologically-based pharmacokinetic model development across different skin disease states
(RFA-FD-18-017)
Food and Drug Administration
Application Receipt Date(s): May 29, 2018, by 11:59 PM Eastern Time.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.
Late applications will not be accepted for this FOA.
-
Formulation drug product quality attributes in dermal physiologically-based pharmacokinetic models for topical dermatological drug products and transdermal delivery systems
(RFA-FD-18-019)
Food and Drug Administration
Application Receipt Date(s): May 28 , 2018, by 11:59 PM Eastern Time.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.
Late applications will not be accepted for this FOA.
-
Three-Dimensional Approach for Modeling Nasal Mucociliary Clearance via Computational Fluid Dynamics (CFD)
(RFA-FD-18-020)
Food and Drug Administration
Application Receipt Date(s): June 4, 2018, by 11:59 PM Eastern Time.
-
Assuring Radiation Protection (U18)
(RFA-FD-18-021)
Food and Drug Administration
Application Receipt Date(s): June 4,2018, by 11:59 PM Eastern Time.